Business Standard

Roche ties up with Wellthy Therapeutics for AI-based diabetes management

The joint offering of the two companies will encompass Accu-Chek Active blood glucose meter and the Wellthy Care app to the new users

Roche

The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel, Switzerland. Photo: Reuters

Press Trust of India New Delhi
Drug firm Roche on Wednesday said it has partnered with Wellthy Therapeutics to offer users of the Accu-Chek Active system, an artificial intelligence-based digital diabetes coaching solution.
The joint offering of the two companies will encompass Accu-Chek Active blood glucose meter and the Wellthy Care app to the new users. The bundle is being launched in the south as well as western parts of the country.
"With Wellthy's digital diabetes health coach, new Accu-Chek Active users can log blood glucose readings into the app to receive 24/7 guidance on understanding and managing their diabetes better. We firmly believe that this joint offering will help in improving the quality of life for Indians living with type 2 diabetes," Roche Diabetes Care India Ad-Interim General Manager Rahul Kedia said.
Wellthy Therapeutics Co-Founder & CEO Abhishek Shah said the partnership marks an important first step, in a larger shared vision to make a meaningful difference in the lives of millions of people living with diabetes.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 31 2018 | 8:05 PM IST

Explore News